Frank GKW, Shott ME, DeGuzman MC. The Neurobiology of Eating disorders. Child Adolesc Psychiatr Clin N Am. 2019;28(4):629–40.

Article  PubMed  PubMed Central  Google Scholar 

Qian J, Wu Y, Liu F, Zhu Y, Jin H, Zhang H, et al. An update on the prevalence of eating disorders in the general population: a systematic review and meta-analysis. Eat Weight Disord. 2022;27(2):415–28.

Article  PubMed  Google Scholar 

Keski-Rahkonen A. Epidemiology of binge eating disorder: prevalence, course, comorbidity, and risk factors. Curr Opin Psychiatry. 2021;34(6):525.

Article  PubMed  Google Scholar 

Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016;29(6):340–5.

Article  PubMed  Google Scholar 

Kirkpatrick RH, Breton E, Biorac A, Munoz DP, Booij L. Non-suicidal self-injury among individuals with an eating disorder: a systematic review and prevalence meta-analysis. Int J Eat Disord. 2024;57(2):223–48.

Article  PubMed  Google Scholar 

van Eeden AE, van Hoeken D, Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2021;34(6):515–24.

Article  PubMed  PubMed Central  Google Scholar 

Barakat S, McLean SA, Bryant E, Le A, Marks P, Aouad P, et al. Risk factors for eating disorders: findings from a rapid review. J Eat Disord. 2023;11(1):8.

Article  PubMed  PubMed Central  Google Scholar 

Linardon J, Hindle A, Brennan L. Dropout from cognitive-behavioral therapy for eating disorders: a meta-analysis of randomized, controlled trials. Int J Eat Disord. 2018;51(5):381–91.

Article  PubMed  Google Scholar 

Schopf K, Schneider S, Meyer AH, Lennertz J, Humbel N, Bürgy NM, et al. Eating disorder treatment in routine clinical care: a descriptive study examining treatment characteristics and short-term treatment outcomes among patients with anorexia nervosa and bulimia nervosa in Germany and Switzerland. PLoS ONE. 2023;18(6):e0280402.

Article  PubMed  PubMed Central  Google Scholar 

Nichols DE. Psilocybin: from ancient magic to modern medicine. J Antibiot (Tokyo). 2020;73(10):679–86.

Article  PubMed  Google Scholar 

Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. Psilocybin as a treatment for Psychiatric illness: a Meta-analysis. Cureus. 2022;14(11):e31796.

PubMed  PubMed Central  Google Scholar 

Calder A, Mock S, Friedli N, Pasi P, Hasler G. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2023;75:1–14.

Article  Google Scholar 

Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS. Psychedelic-assisted therapy for people with eating disorders. Curr Psychiatry Rep. 2022;24(12):767–75.

Article  PubMed  Google Scholar 

Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, et al. Molecular mechanisms of psilocybin and implications for the treatment of Depression. CNS Drugs. 2022;36(1):17–30.

Article  PubMed  Google Scholar 

Carhart-Harris RL, Friston KJ. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Barker EL, editor. Pharmacol Rev. 2019;71(3):316–44.

Haynos AF, Camchong J, Pearson CM, Lavender JM, Mueller BA, Peterson CB, et al. Resting state hypoconnectivity of reward networks in binge eating disorder. Cereb Cortex N Y N 1991. 2021;31(5):2494–504.

Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, et al. Psilocybin-Induced decrease in Amygdala Reactivity correlates with enhanced positive Mood in healthy volunteers. Biol Psychiatry. 2015;78(8):572–81.

Holze F, Avedisian I, Varghese N, Eckert A, Liechti ME. Role of the 5-HT2A receptor in Acute effects of LSD on Empathy and circulating oxytocin. Front Pharmacol. 2021;12:711255.

Nardou R, Sawyer E, Song YJ, Wilkinson M, Padovan-Hernandez Y, de Deus JL, et al. Psychedelics reopen the social reward learning critical period. Nature. 2023;618(7966):790–8.

Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies. Acta Psychiatr Scand. 2021;143(2):101–18.

Article  PubMed  Google Scholar 

Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol. 2018;11(9):889–902.

Article  PubMed  Google Scholar 

Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR. The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis. Psychiatry Res. 2020;284:112749.

Article  PubMed  Google Scholar 

Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G et al. Psychedelic Therapy’s Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. Front Psychiatry [Internet]. 2021 Dec 17 [cited 2024 May 9];12. Available from: https://www.frontiersin.org/journals/psychiatry/articles/https://doi.org/10.3389/fpsyt.2021.800072/full

Kočárová R, Horáček J, Carhart-Harris R. Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Front Psychiatry [Internet]. 2021 Jul 19 [cited 2024 May 9];12. Available from: https://www.frontiersin.org/journals/psychiatry/articles/https://doi.org/10.3389/fpsyt.2021.661233/full

Capaldi JM, Shabanian J, Finster LB, et al. Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions. Health Psychol Rev. 2024;18(1):41–74. https://doi.org/10.1080/17437199.2022.2162947

Koning E, Brietzke E. Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence. Trends Psychiatry Psychother. 2024;46:e20220597. https://doi.org/10.47626/2237-6089-2022-0597

Ledwos N, Rodas JD, Husain MI, Feusner JD, Castle DJ. Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder. J Psychopharmacol (Oxf). 2023;37(1):3–13.

Article  Google Scholar 

Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M. But the reality is it’s happening: a qualitative study of eating disorder providers about psilocybin-assisted psychotherapy. Int J Eat Disord. 2023;56(11):2142–8.

Article  PubMed  Google Scholar 

Otterman LS. Research into psychedelic-assisted psychotherapy for Anorexia Nervosa should be funded. J Bioethical Inq. 2023;20(1):31–9.

Article  Google Scholar 

Attia E, Steinglass JE. Psilocybin for anorexia nervosa: if it helps, let’s learn how. Med. 2023;4(9):581–2.

Article  PubMed  Google Scholar 

E-Wen McCulloch D, Liechti ME, Kuypers KPC, Nutt D, Lundberg J, Stenbæk DS, et al. Knowledge gaps in psychedelic medicalisation: clinical studies and regulatory aspects. Neurosci Appl. 2024;3:103938.

Article  Google Scholar 

Cammisuli DM, Castelnuovo G. Neuroscience-based psychotherapy: a position paper. Front Psychol. 2023;14:1101044.

Article  PubMed  PubMed Central  Google Scholar 

Frank GKW. Advances from neuroimaging studies in eating disorders. CNS Spectr. 2015;20(4):391–400.

Article  PubMed  PubMed Central  Google Scholar 

Geyer MA. A Brief Historical Overview of Psychedelic Research. Biol Psychiatry Cogn Neurosci Neuroimaging [Internet]. 2023 Nov 23 [cited 2024 Jan 16]; Available from: https://www.sciencedirect.com/science/article/pii/S2451902223003142

Rieser NM, Schmidt TT, Preller KH. Neurobiological correlates of psychedelic experiences and Psychedelic-Associated adverse effects. Curr Top Behav Neurosci; 2024.

Geva T. Magnetic resonance imaging: historical perspective. J Cardiovasc Magn Reson off J Soc Cardiovasc Magn Reson. 2006;8(4):573–80.

Google Scholar 

Curzio O, Calderoni S, Maestro S, Rossi G, De Pasquale CF, Belmonti V, et al. Lower gray matter volumes of frontal lobes and insula in adolescents with anorexia nervosa restricting type: findings from a Brain Morphometry Study. Eur Psychiatry J Assoc Eur Psychiatr. 2020;63(1):e27.

Article  Google Scholar 

Vidal L, Ortega MA, Alvarez-Mon MA, Álvarez-Mon M, Lahera G. Volumetric alterations of the cerebral cortex in eating disorders. J Clin Med. 2021;10(23):5480.

Article  PubMed  PubMed Central  Google Scholar 

Amianto F, Caroppo P, D’Agata F, Spalatro A, Lavagnino L, Caglio M, et al. Brain volumetric abnormalities in patients with anorexia and bulimia nervosa: a voxel-based morphometry study. Psychiatry Res. 2013;213(3):210–6.

Article  PubMed  Google Scholar 

Titova OE, Hjorth OC, Schiöth HB, Brooks SJ. Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies. BMC Psychiatry. 2013;13:110.

Article  PubMed  PubMed Central  Google Scholar 

Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A, Ribeiro S, Sanches R, Crippa JAS, et al. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2015;25(4):483–92.

Article  Google Scholar 

Lewis CR, Preller KH, Braden BB, Riecken C, Vollenweider FX. Rostral anterior cingulate thickness predicts the emotional psilocybin experience. Biomedicines. 2020;8(2):34.

Article  PubMed  PubMed Central  Google Scholar 

Brodrick BB, Adler-Neal AL, Palka JM, Mishra V, Aslan S, McAdams CJ. Structural brain differences in recovering and weight-recovered adult outpatient women with anorexia nervosa. J Eat Disord. 2021;9:108.

Article  PubMed  PubMed Central